Citation: Mpm. Stokkel et al., Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology, EUR ARCH OT, 257(10), 2000, pp. 552-554
Authors:
Verhaar-Langereis, MJ
Bongers, V
de Klerk, JMH
van Dijk, A
Blijham, GH
Zonnenberg, BA
Citation: Mj. Verhaar-langereis et al., Interferon-alpha induced changes in CEA expression in patients with CEA-producing tumours, EUR J NUCL, 27(2), 2000, pp. 209-213
Authors:
van de Ven, PJG
de Klerk, JMH
Mertens, IJR
Koomans, HA
Beutler, JJ
Citation: Pjg. Van De Ven et al., Aspirin renography and captopril renography in the diagnosis of renal artery stenosis, J NUCL MED, 41(8), 2000, pp. 1337-1342
Authors:
de Klerk, JMH
de Keizer, B
Zelissen, PMJ
Lips, CMJ
Koppeschaar, HPF
Citation: Jmh. De Klerk et al., Fixed dosage of I-131 for remnant ablation in patients with differentiatedthyroid carcinoma without pre-ablative diagnostic I-131 scintigraphy, NUCL MED C, 21(6), 2000, pp. 529-532
Authors:
Mertens, IJR
de Klerk, JMH
Zelissen, PMJ
Thijssen, JHH
Sie-Go, DMDS
Han, SH
van Rijk, PP
Citation: Ijr. Mertens et al., Undetectable serum thyroglobulin in a patient with metastatic follicular thyroid cancer, CLIN NUCL M, 24(5), 1999, pp. 346-349
Authors:
de Klerk, JMH
Zonnenberg, BA
Schip, ADV
Van Dijk, A
Huiskes, AWLC
Van Rijk, PP
Citation: Jmh. De Klerk et al., Can bone marrow scintigraphy predict platelet toxicity after treatment with Re-186-HEDP?, NUCL MED C, 20(9), 1999, pp. 833-836